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ability to be formed under a wide range of (patho)physiological conditions. [ 15 ] Therefore, in addition to NO 2 − and nitrate, which have previously been explored for therapeutic delivery as prodrugs, [ 16 ] R-SNO represent an attractive and physiological NO chemistry that has been exploited to harness both native NO signaling and transport activity in biological systems. [ 17 ] Brugia malayi , one of three fi larial worms responsible for lymphatic fi lariasis, are transmitted through a mosquito's saliva, injected into a host's dermis, where they make their way to the lymphatics, grow and multiply, and can eventually cause several chronic diseases including elephantiasis. [ 18 ] There are an estimated 120 million people, most of whom reside in the developing world, who harbor these parasites with another 1 billion people identifi ed as at risk for infection. [ 19 ] While there are several treatment options available to remove the microfi laria progeny that spread the disease, there are no lymphaticlocalized therapies that target the adult worms in the lymphatics where they reside. Hence, people currently infected face few treatment options. [ 19 ] NO has been implicated as an effector cytotoxic molecule in the immune response to a variety of pathogenic parasites. [ 18, 20, 21 ] Previous work has shown that B. malayi are susceptible to exogenously delivered NO [ 22 ] and demonstrated potential for physiological R-SNO, SNO-CYS, [ 23 ] and S-nitrosoglutathione, [ 24 ] to mediate damage to several types of parasites. Due to their small size, however, commercially available NO donors and physiological R-SNO have low potential after injection to accumulate within lymphatic vessels [ 25, 26 ] where these parasites reside, curbing their utility as antifi larial therapeutic agents. Whereas small molecules < 5 nm in hydrodynamic size are freely blood permeable and are thus rapidly cleared into the systemic circulation, [ 25 ] drug targeting to lymphatics is signifi cantly enhanced for nanoscale drug delivery systems ≈30 nm in hydrodynamic size [ 25 ] and NO formulation approaches improve both donor circulation times [ 27 ] and NO bioactivity. [ 28 ] A NO-encapsulating nanoformulation could therefore facilitate the targeted, controlled, and effi cient delivery of NO to eradicate fi larial parasites resident within lymphatic tissues.
Herein, we report the synthesis and modifi cation of thiolated nanoparticles (NP) with NO in order to harness the physiological nitrosothiol chemistry for NO delivery and bioactivity using a synthetic polymer system. These NO-containing nanoparticles (SNO-NP) stably encapsulate high levels of NO and facilitate its controlled release. In particular, we demonstrate that the bioactive form of released NO from SNO-NP, either NO 2 − or SNO -CYS, depends on the ratio of free cysteine (CYS), a common endogenous low molecular weight thiol important Nitric oxide (NO) mediates its effects through its chemistry in a variety of physiological signaling processes including vasodilation, [ 1 ] inhibition of platelet aggregation, [ 2 ] and cytotoxicity [ 3 ] in a manner analogous to phosphorylation. [ 4 ] NO is highly diffusive, but due to its chemical reactivity is purported to have an extremely short half-life on the order of 5-10 s. [ 5 ] Controlled delivery and release strategies for NO are thus highly attractive for a range of therapeutic applications, [ 6 ] but challenging to achieve within deep tissue targets. [ 7 ] To enable NO's physiological effects to be exerted over much farther distances than its reactivity-limited diffusion distance would permit, NO in situ can form reversible adducts with endogenous nucleophiles [ 8 ] or convert to its more stable oxidized forms, nitrite (NO 2 − ) and nitrate, [ 9 ] all of which can revert to NO under certain physiological conditions. [ 9, 10 ] Endogenous nitrosothiols (R-SNO), which include S-nitrosocysteine (SNO-CYS), S-nitroso-albumin, and S-nitrosoglutathione, represent a major class of NO adducts that facilitate NO's transport in vivo. [ 11 ] R-SNO are formed on free thiols either through reactions with nitrosating agents [ 12 ] or by transnitrosation (i.e., by transfer of NO from other nitrosothiols) [ 13, 14 ] giving R-SNO the in transnitrosation reactions, [ 15 ] to SNO-NP. Furthermore, the cytotoxic activity of SNO-NP against B. malayi adult female fi larial worms, for which there is no existing treatment, is accelerated in the presence of CYS due to the formation of SNO-CYS. Since these synthetic NP have well-documented lymphatic targeting activity after intradermal injection, [ 30 ] these results provide a strong rationale for therapeutic use of SNO-NP in eradication of B. malayi that reside intralymphatically in vivo and for other deep tissue NO delivery applications.
SNO-NP were formed by S -nitrosation of synthetic thiolated NP synthesized by emulsion polymerization [ 31 ] ( Figure 1 a) . Amphiphilic block copolymer Pluronics, including F127 (PF127) explored here as well as F68, [ 32 ] self-assemble in water to form micelles, which are able to make an emulsion with propylene sulfi de and, in the presence of a deprotected thiolated initiator, activate living anionic polymerization within the micelle core. As the concentration of initiator was varied, different degrees of polymerization of poly(propylene sulfi de) (PS) were achieved ( Figures S1-S4 , Supporting Information). This resulted in an increasing concentration of free thiols (SH) (Figure 1 b) as well as ratio of SH to disulfi de ( Figure S5 , Supporting Information) at the completion of polymerization after solution oxidation with increasing concentration of added initiator with little to no effect on NP size (Figure 1 c) . Dialyzed NP were subsequently S -nitrosated by introduction of acidifi ed nitrite, enabling formation of NO S -nitroso adducts (SNO) with the NP core free thiols. With increasing concentration of NP SH there was a proportional increase in SNO concentration To confi rm SNO adduct formation within NP, SNO-NP were analyzed via UV-vis absorbance. SNO-NP exhibited the characteristic absorbance wavelength of primary thiol S -nitroso adducts at ≈340 nm, [ 29 ] that increased with concentration ( Figure 1 e) giving a molar extinction coeffi cient of 540 M −1 cm −1 (Figure 1 e, inset) consistent with previously reported R-SNO. [ 13 ] Furthermore, the SNO signal coeluted with that of the thiolated NP during column chromatography ( Figure 1 f) , demonstrating the stability of the SNO adduct. Additionally, over the course of dialysis at room temperature against water in a membrane with a 100 000 molecular weight cut off, SNO signal did not decline appreciably while free NO 2 − from the S-nitrosation process was effectively removed as the pH of SNO-NP was brought to physiological levels (Figure 1 g ).
We next explored the release of NO from SNO-NP under physiological conditions. In complete serum-containing media at 37 °C, decay of SNO signal from 1 × 10 −3 M of SNO-NP over 100 h was comparable to that of 1 × 10 −3 M of S -nitroso-N -acetyl penicillamine (SNAP), a commercially available synthetic small molecule NO donor [ 10 ] that is similar in size and structure to some endogenous R-SNO, which has been extensively used to study a wide variety of NO-regulated processes including infl ammation, [ 33 ] vasodilation, [ 34 ] and inhibition of platelet aggregation. [ 10 ] The rate of NO release from SNO-NP was not infl uenced by the degree of PS polymerization ( Figure S6 , Supporting Information). At 6 and 24 h post incubation, however, SNO-NP exhibited faster release (32% and 70%, respectively) of SNO relative to SNAP (7% and 50%) ( Figure 2 a) . In distinct contrast to SNAP, SNO-NP also resulted in the signifi cant accumulation over time of NO 2 − (Figure 2 a) , likely resulting from preferential reaction with oxygen due to its increased concentration within the hydrophobic NP core, in which oxygen is more soluble than aqueous media. [ 35 ] SNAP, on the other hand, being a small molecule NO donor that releases NO directly into a less oxygen dense environment [ 8 ] that may have potential for interactions with serum species, [ 36 ] results in no NO 2 − accumulation. We next evaluated whether SNO-NP could donate NO to physiological thiols through transnitrosation. [ 13 ] In complete medium, the free thiol concentration was found to be <0.025 × 10 −3 M as measured by Ellman's assay. To probe how the presence of free thiols may drive transnitrosation, we added CYS and monitored SNO decay from SNO-NP and the formation of NO 2 − over time (Figure 2 b-c) . CYS was mixed with 1 × 10 −3 M of SNO-NP at the following ratios of CYS:SNO-NP (i.e., SH from CYS to SNO from SNO-NP): 0:1, 0.1:1, 1:1, and 10:1. CYS to SNO-NP ratios of 1:1 and 10:1 accelerated the decay of SNO signal from SNO-NP relative to low and zero CYS ratios (Figure 2 b) . However, an increase in SNO signal that was not statistically signifi cant was observed at long times after coincubation for the highest ratio tested (10:1, Figure 2 
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from SNO-NP by either of two distinct pathways: to NO 2 − in the case of low or no free thiols or to R-SNO via transnitrosation in the case of high thiol concentration (Figure 2 d) .
To test this hypothesis, the extent of transnitrosation as determined by the formation of SNO-CYS after coincubation of 1 × 10 −3 M of SNO-NP with varying ratios of CYS was determined. Since the Saville assay could not discriminate between SNO retained by SNO-NP versus that from newly created SNO-CYS via transnitrosation, the two SNO species were separated using size exclusion column chromatography after prescribed times of coincubation. This technique was able to detect the ratio of remaining SNO amongst the two species, SNO-NP and SNO-CYS, by comparing the collected fractions to those previously obtained for the individual species (Figure 2 e) . By virtue of their larger size, NP eluted in early fractions, whereas small CYS eluted in later fractions as verifi ed by Ellman's assay and iodine staining. [ 30 ] We found that SNO-CYS constituted a larger percent of remaining SNO at late times for all CYS to SNO-NP ratios tested but only represented a signifi cant portion of the remaining SNO for 10:1 CYS:SNO-NP (Figure 2 f) . In terms of absolute amount, this corresponded with an appreciable increase in SNO-CYS concentration for only the 10:1 CYS to SNO-NP (Figure 2 g ). The extent of transnitrosation by SNO-NP was not appreciably affected by degree of PS polymerization ( Figure S7, Supporting Information) .
To demonstrate SNO-NP function as an antiparasitic agent, we devised a setup in which adult female worms were individually incubated in wells containing complete medium and quantifi ed motility over 96 h. We have previously used a similar experimental confi guration to monitor worm motility and health over time as well as evaluate worm responses to antiparasitic agents. Worm motility in response to treatment normalized to pretreatment was then plotted over time. Concentrations of NO treatment groups ranged from 1× 10 −3 to 2 × 10 −3 M .
We found that the motility of SNAP-treated worms decreased quickly upon coincubation with SNAP, while control N -acetyl penicilamine (NAP)-treated worms showed no reduction ( Figure 3 a) . Treatment with SNO-NP but not NP alone also resulted in a reduction of worm motility though the response was much delayed relative to SNAP (Figure 3 a) . However, the death curve (Figure 3 
similar for both SNAP and SNO-NP treated worms. We hypothesized that this discrepancy in effect on motility but not time until death may result from SNAP but not SNO-NP penetration into the worms in order to mediate its effects. This idea is supported by fi ndings that the worm's cuticle, the highly cross-linked collagenous structure lining the worm's limiting membrane, [ 38 ] is impermeable to large antibody and complement complexes, [ 39 ] but not to small molecules such as glucose or amino acids, thus making it impermeable to the SNO-NP. [ 40 ] Furthermore, it has been previously hypothesized that endogenous R-SNO, which are similar in molecular weight and hydrodynamic size to SNAP, mediate antiparasitic effects through their uptake by worms as the result of their similarity to natural analogues [ 23 ] and by S-nitrosating key proteins [ 41 ] such as cysteine proteases. [ 21, 42 ] To test this hypothesis, worms were incubated with SNO-NP in the presence of 0:1, 0. (Figure 3 e), may be a result of the higher amount of total SNO-CYS created when CYS is added at a high ratio relative to SNO-NP (Figure 3 f) . It should be noted that though cysteine is present in the lymph at ≈100 × 10 −6 M , [ 43 ] SNO-NP undergo signifi cant dilution following intradermal administration, accumulating within lymph in draining lymph nodes at a ≈30-100-fold lower concentration relative to that administered in the dermis. [ 30 ] Hence if the dose used in vitro here was administrated intradermally, SNO-NP would still result in CYS:SNO-NP ratios >3-10. Additionally, SNO-CYS (187 Da), which is approximately the same size as SNAP (220 Da), may kill the worms faster either because it is absorbed more quickly than SNAP or because it is better at mediating the effects of the NO it carries. In addition to their higher potential for lymphatic targeting relative to SNAP, these results highlight the potential for SNO-NP to effectively treat parasites through its unique NO-releasing mechanisms.
In conclusion, we have demonstrated the synthesis and characterization of SNO-NP for the delivery of NO reservoirs NO 2 − and R-SNO. We demonstrate that SNO-NP release SNO through either the formation of NO 2 − or by transnitrosation. Furthermore, we establish antiparasitic activity of SNO-NP corresponding with the extent of R-SNO formation determined by the relative ratio of CYS to SNO-NP (Figure 3 f) . Implementing a synthetic polymer nanoformulation to deliver high levels of per NP NO via the physiological S -nitrosothiol chemistry represents an innovative approach to achieve therapeutic delivery of NO. Given the unique and previously reported lymphatic targeting activity of these NP, this represents a novel formulation for the delivery of NO in the elimination of adult female fi larial worms.
Experimental Section
Synthesis and Characterization of SNO-NP : NP were synthesized as previously described. [ 30, 31 ] Briefl y, 500 mg of Pluronic F127 (SigmaAldrich, St. Louis, MO, USA, P2443) was added to 10 mL of degassed Milli-Q water, allowed to dissolve for 30 min with stirring, and was again degassed. To this solution, 400 µL of propylene sulfi de (SigmaAldrich, P53209) was added under argon and stirred for 30 min. Initiator weighing 7.8, 14.4, 28.8, or 43.4 mg (1.9, 3.7, 7.4, and 11 × 10 −3 M , respectively) was reacted with 322 µL of sodium methoxide (SigmaAldrich, 156256) and then added under argon. 1,8-Diazabicyclo [5.4 .0] undec-7-ene (DBU) (Sigma-Aldrich, 139009) was added under argon to the solution 15 min later and the entire reaction stirred for 24 h. The solution was subsequently exposed to air for 2 h and dialyzed for 3 d against 4 × 5 L of Milli-Q water using 100 000 Da molecular weight cut off cellulose membrane dialysis tubing (Spectrum Lab., Rancho Dominguez, CA, USA, 131414). NP size was measured by dynamic light scattering and a small volume was lyophilized to obtain the total NP weight concentration. 1 H nuclear magnetic resonance (400 MHz, CDCl 3 ) was used to calculate the weight percent of Pluronic F127, poly(propylene sulfi de), and initiator in the NP. [ 31 ] In reactions where excess acidifi ed nitrite was removed, an eightfold molar excess of ammonium sulfamate was added to the solution. The Saville assay, [ 45 ] which measures S -nitrosothiol concentration, was performed by mixing 70 µL of the S -nitrosated thiol solution with 100 µL of Solution A (one part mercuric chloride solution and four parts sulfanilamide solution) or 100 µL of Solution B (one part water and four parts sulfanilamide solution) and then mixing these solutions with 80 µL of 5.4 × 10 −3 M N -(1-naphthyl)ethylenediamine dihydrochloride solution. The Griess assay, which measures free NO 2 − , is the same as the Saville, except without the addition of Solution A. For both assays, after 10 min incubation at room temperature, the absorbance was read at 540 nm and the difference between Solution A and Solution B represents the S -nitrosothiol signal. S -nitrosothiol and free NO 2 − concentrations were calculated from a standard curve of S -nitrosoglutathione. [ 46 ] Degradation and Transnitrosation Studies : SNO-NP were prepared by the standard S -nitrosation procedure described above. SNO-NP were then dialyzed with 100 000 Da molecular weight cut off cellulose membrane dialysis tubing against 5 L of Milli-Q water overnight. Following dialysis, SNO-NP were brought to pH 7.4 using 10× PBS without calcium and magnesium and diluted to 1-2 × 10 −3 M NO concentration in complete medium. SNAP solutions were made in PBS, [ 47 ] at the University of Georgia (Athens, GA, USA). Upon receipt, worms were washed and resuspended in 50 mL of complete medium (endothelial basal medium (Lonza, New York, USA) supplemented with 20% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA, USA), 1% glutamax, 1% penicillin-streptomycinamphotericin (Gibco, New York, NY, USA), 25 mg mL −1 cyclic-AMP and 1 mg mL −1 hydrocortisone acetate (both from Sigma-Aldrich)). The worms were then maintained at 37 °C in a 5% CO 2 incubator for at least 18 h prior to experimentation. Individual worms were subsequently plated in 2.5 mL of complete medium in a 24-well culture plate preincubated at 37 °C in a 5% CO 2 for 1 h prior to the addition of worms. All treatment solutions were prepared the day of the experiment, except SNO-NP, which were S -nitrosated and dialyzed the prior evening. All treatment solutions were prepared in 1× PBS without calcium and magnesium at a pH of 7.4. 500 µL of each treatment was added to the worms in replicates of four. Following the addition of treatments, the worms were incubated and 5 s video segments at 10 min intervals were recorded using a custom imaging hardware assembled and maintained within the incubator. Worm motility was quantifi ed using a Lucas-Kanade optical fl ow algorithm implemented in LabVIEW (National Instruments, Austin, TX). The velocity vectors obtained between two subsequent frames were summed for an entire worm-containing well and then averaged over the length of the video segment giving us the motility metric. Worm death was defi ned when the motility metric (normalized to pretreatment baseline) fell and remained below 10% of its normalized value. The 10% threshold was used after it was determined that below that the algorithm was quantifying noisy pixels due to vibrations in the incubator. Data representative of individual treatment groups run in quadruplets in two to fi ve independently run experiments.
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Statistical Analysis : Data are expressed as mean ± standard deviation. Statistical analysis was carried out using Prism 6 (GraphPad Software Inc. La Jolla, CA, USA). Death curves were analyzed using a Log-rank (Mantel-Cox) test for signifi cance. Time until death was analyzed using an ordinary unpaired one-way analysis of variance (ANOVA) with Tukey multiple comparison correction. Statistical signifi cance was defi ned as and represented by p ≤ 0.05 (*), p ≤ 0.01 (**), and p ≤ 0.001 (*** and § § §).
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